Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission.
Lv M, Wang Y, Chang YJ, Zhang XH, Xu LP, Jiang Q, Jiang H, Lu J, Chen H, Han W, Wang FR, Wang JZ, Chen Y, Yan CH, Zhang YY, Sun YQ, Mo XD, Zhu HH, Jia JS, Zhao T, Wang J, Liu KY, Huang XJ.
Lv M, et al. Among authors: wang fr, wang jz, wang j, wang y.
Clin Cancer Res. 2019 Mar 15;25(6):1737-1748. doi: 10.1158/1078-0432.CCR-18-1637. Epub 2018 Nov 26.
Clin Cancer Res. 2019.
PMID: 30478089
Clinical Trial.